Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP

Last updated on 2022-08-21 History
Report ID 163521
Drug Identification Number 02139510
Brand name SODIUM CHLORIDE INJECTION, USP
Common or Proper name SODIUM CHLORIDE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 234MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 30 ML
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-07-01
Actual start date 2022-07-01
Estimated end date 2022-08-15
Actual end date 2022-08-15
Shortage status Resolved
Updated date 2022-08-21
Company comments We will be extending our backorder on Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL until August 15, 2022. Once available, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-08-21 French Compare
v6 2022-08-21 English Compare
v5 2022-07-29 French Compare
v4 2022-07-29 English Compare
v3 2022-07-02 English Compare
v2 2022-06-27 French Compare
v1 2022-06-27 English Compare

Showing 1 to 7 of 7